Literature DB >> 2847561

CRF activates autonomic nervous system and reduces natural killer cytotoxicity.

M Irwin1, R L Hauger, M Brown, K T Britton.   

Abstract

Corticotropin-releasing factor (CRF) acts within the brain to elicit changes in neuroendocrine, autonomic, and behavioral activity similar to those observed after stress. A reduction of immune function has also been described following central administration of CRF. In this study, we examined whether autonomic nervous system activation plays a role in CRF-induced suppression of natural killer (NK) cytotoxicity. synthetic rat CRF (1.0 microgram) microinjected into the lateral ventricle significantly increased plasma concentrations of norepinephrine and reduced splenic NK cell activity in the rat. Pretreatment of the animals with the ganglionic-blocking agent chlorisondamine completely abolished the CRF-induced increase in plasma norepinephrine levels and reduction in NK activity. However, CRF-induced elevations in plasma levels of adrenocorticotropic hormone and corticosterone were not affected by chlorisondamine. The results of this study suggest that activation of the sympathetic nervous system plays a role in CRF-induced suppression of NK cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847561     DOI: 10.1152/ajpregu.1988.255.5.R744

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

Review 3.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

4.  Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

Authors:  J C Bittencourt; P E Sawchenko
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

5.  Phenytoin promotes Th2 type immune response in mice.

Authors:  K Okada; T Sugiura; E Kuroda; S Tsuji; U Yamashita
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

6.  Hypothalamic modulation of splenic natural killer cell activity in rats.

Authors:  T Katafuchi; T Ichijo; S Take; T Hori
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

Review 7.  Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection.

Authors:  J F Sheridan; C Dobbs; D Brown; B Zwilling
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 8.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

9.  Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat.

Authors:  T Katafuchi; S Take; T Hori
Journal:  J Physiol       Date:  1993-06       Impact factor: 5.182

10.  Sympathetic innervation of the spleen in male Brown Norway rats: a longitudinal aging study.

Authors:  Sam D Perez; Dorian Silva; Ashley Brooke Millar; Christine A Molinaro; Jeff Carter; Katie Bassett; Dianne Lorton; Paola Garcia; Laren Tan; Jonathon Gross; Cheri Lubahn; Srinivasan Thyagarajan; Denise L Bellinger
Journal:  Brain Res       Date:  2009-09-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.